Halopredone
Top View
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- (12) United States Patent (10) Patent No.: US 8,080,553 B2 Keith Et Al
- United States Patent (10) Patent No.: US 9,555,047 B2 Bodick Et Al
- TAR/W/87 21 Juin 1993 DOUANIERS ET LE COMMERCE Distribution Limitée
- Customs Tariff - Schedule Xxi - 1
- (12) United States Patent (10) Patent No.: US 9,682,078 B2 Botchwey, III Et Al
- (12) United States Patent (10) Patent No.: US 7,368.442 B2 Del Soldato (45) Date of Patent: *May 6, 2008
- Literature Search Strategy for Treatment of Stable
- Harmonized Tariff Schedule of the United States (2006) (Rev
- General Agreement on Tariffs Andtrade
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Figure 1 METHODS and COMPOSITIONS for the TREATMENT of DISORDERS ASSOCIATED with DEFECTS of the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE OR PROTEIN
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Pharmaceutical Appendix to the Tariff Schedule 2
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Pharmaceuticals Appendix
- Medicinal Chemistry of Steroids
- Dexamethasone As an Adjuvant to Peripheral Nerve Block (Review)